Reply to the Letter written by Hardeman

Articles in the same Issue

1. CCLM: Bringing advances in laboratory medicine to the “New World”
2. Diagnostic approach to inherited bleeding disorders
3. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research
4. Association between polymorphisms of ACE, B2AR, ANP and ENOS and cardiovascular diseases: a community-based study in the Matsu area
5. Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay
6. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients
7. Surrogate markers of insulin resistance in assessing individuals with new categories “prehypertension” and “prediabetes”
8. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability
9. Hyperhomocysteinaemia and immune activation in patients with cancer
10. The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers
11. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21
12. Pregnancy-associated plasma protein A in dialysis patients
13. L-Cysteine supplementation prevents exercise-induced alterations in human erythrocyte membrane acetylcholinesterase and Na⁺,K⁺-ATPase activities
14. Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease
15. Increased adenosine deaminase in hydatidiform mole
16. Classification tree analysis for the discrimination of pleural exudates and transudates
17. External quality assessment of hemoglobin A₂ measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems
18. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine
19. Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: an update
20. Analytical validation of the new version of the Liaison N-Tact PTH assay
21. Validation of an automated sensitive immunoassay for quantitation of cytokines in the sputum of cystic fibrosis patients
22. Strong interference of hemoglobin concentration on CSF total protein measurement using the trichloroacetic acid precipitation method
23. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach
24. Acquiring a measurement system within the framework of standard ISO 15189
25. Six Sigma and laboratory consultation
26. ESR or LSRB, that is the question!
27. Reply to the Letter written by Hardeman
28. Natriuretic peptides. The hormones of the heart